Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial
- Robert J. Motzer
- , Brian I. Rini
- , David F. McDermott
- , Bruce G. Redman
- , Timothy M. Kuzel
- , Michael R. Harrison
- , Ulka N. Vaishampayan
- , Harry A. Drabkin
- , Saby George
- , Theodore F. Logan
- , Kim A. Margolin
- , Elizabeth R. Plimack
- , Alexandre M. Lambert
- , Ian M. Waxman
- , Hans J. Hammers
- Memorial Sloan-Kettering Cancer Center
- Cleveland Clinic Foundation
- Dana-Farber/Harvard Cancer Center
- University of Michigan, Ann Arbor
- Northwestern University
- Duke University
- Wayne State University
- Medical University of South Carolina
- Roswell Park Cancer Institute
- Indiana University Bloomington
- Stanford University
- Bristol-Myers Squibb
- Johns Hopkins University
Research output: Contribution to journal › Article › peer-review
976
Scopus
citations